EA-5309

EA-5309
Clinical data
ATC code	none;
Identifiers
	IUPAC name 8-8-(4-(p-Trifluoromethylphenyl)-4,4-ethylenedioxy-1-butyl]-3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5.1]-decane;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C27H32F3N3O3
Molar mass	503.566 g·mol−1
	InChI InChI=1/C27H32F3N3O3/c1-31-20-33(23-6-3-2-4-7-23)25(24(31)34)13-16-32(17-14-25)15-5-12-26(35-18-19-36-26)21-8-10-22(11-9-21)27(28,29)30/h2-4,6-11H,5,12-20H2,1H3;

Script error: No such module "AfC submission catcheck".

EA-5309 is a spirocyclic derivative related to butyrophenone. It is based on the series of compounds originating from the laboratories of P. A. J. Janssen. EA-5309 is a skeleton-modified butyrophenone, conferring enhanced biological activity.^[1]

References[edit]

↑ EDGEWOOD ARSENAL TECHNICAL REPORT. EATR 4612. SYNTHESIS OF SPIROCYCLIC DERIVATIVES RELATED TO THE BUTYROPHENONE NEUROLEPTICS. by Leon J. Schiff and Patrick J. Mudd

This article "EA-5309" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:EA-5309. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

[1] EDGEWOOD ARSENAL TECHNICAL REPORT. EATR 4612. SYNTHESIS OF SPIROCYCLIC DERIVATIVES RELATED TO THE BUTYROPHENONE NEUROLEPTICS. by Leon J. Schiff and Patrick J. Mudd

[1]

Clinical data

ATC code	none
Identifiers
IUPAC name 8-8-(4-(p-Trifluoromethylphenyl)-4,4-ethylenedioxy-1-butyl]-3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5.1]-decane
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C₂₇H₃₂F₃N₃O₃
Molar mass	503.566 g·mol⁻¹
InChI InChI=1/C27H32F3N3O3/c1-31-20-33(23-6-3-2-4-7-23)25(24(31)34)13-16-32(17-14-25)15-5-12-26(35-18-19-36-26)21-8-10-22(11-9-21)27(28,29)30/h2-4,6-11H,5,12-20H2,1H3

EA-5309

References[edit]

📰 Article(s) of the same category(ies)[edit]